NONSMALL-CELL LUNG CANCER
Clinical trials for NONSMALL-CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new NONSMALL-CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for NONSMALL-CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for lung cancer: first human trial of DZD6008 begins
Disease control Recruiting nowThis study tests a new drug called DZD6008 for people with advanced non-small cell lung cancer that has a specific EGFR mutation. It is the first time this drug is being tested in humans. The main goals are to check safety, find the right dose, and see if the drug shrinks tumors.…
Matched conditions: NONSMALL-CELL LUNG CANCER
Phase: PHASE1 • Sponsor: Dizal Pharmaceuticals • Aim: Disease control
Last updated May 01, 2026 16:00 UTC
-
New radiation drug targets Hard-to-Treat cancers in first human trial
Disease control Recruiting nowThis early-stage study tests a new drug that delivers radiation directly to cancer cells with a specific marker (GRPR). It is for adults with advanced cancers like prostate, breast, lung, or colon cancer that have come back or spread. The main goals are to find a safe dose and ch…
Matched conditions: NONSMALL-CELL LUNG CANCER
Phase: PHASE1 • Sponsor: Orano Med LLC • Aim: Disease control
Last updated Apr 30, 2026 15:51 UTC